Christopher L.-H. Huang

Christopher Li-Hur Huang (born 28 December 1951) is an Asian-British physiologist and academic, known for his contributions in cellular physiology. He is Emeritus Professor of Cell Physiology at the University of Cambridge and Fellow Emeritus of Murray Edwards College, Cambridge, UK.

Huang's research addresses the generation, propagation and transduction of biological signals at the cellular and systems levels. It particularly focusses on the mechanisms underlying skeletal and cardiac muscle activation.

Early life and education Christopher Huang was born in Singapore in 1951. His school education was in Malaysia and Singapore, the latter culminating in award of a President's Scholarship. He was elected to a Florence Heale Open Scholarship at The Queen's College, University of Oxford, to read for a B.A. in Physiological Sciences conferred in 1974, and clinical training, with medical degrees (B.M., B.Ch.) conferred in 1976. He was subsequently conferred degrees of D.M. by Oxford in 1985, M.D. by Cambridge in 1986, and D.Sc. (Oxford) and Sc.D. (Cambridge) both in 1995. He was elected Fellow of The Royal Society of Biology (FRSB) in 2011, European Society of Cardiology (FESC) in 2016, Physiological Society (FTPS) in 2017, and Sigma Xi in 2025. He is a recipient of the Benefactor's and Brian Johnson (Oxford), Gedge (Cambridge) and LEPRA (British Leprosy Relief Association) Prizes.

Research Huang's research has focused on biophysical mechanisms of signal transduction and propagation in excitable tissues. These multidisciplinary studies employed electrophysiological, confocal, electron microscopic and magnetic resonance imaging, and mathematical modeling, methods.

His early work explored striated muscle excitation-contraction coupling and osteoclastic bone resorption, clarifying their activation mechanisms and local and systemic, control and feedback modulation. He also modelled the cell electrolyte homeostasis underpinning these processes. He is best known for his work on cardiac electrophysiology and arrhythmogenesis in murine models of inherited and acquired cardiac clinical conditions.

Industrial and Translational Work

Of pharmaceutical and biotechnology companies, Huang has collaborated with GlaxoSmithKline (GSK), Xention, NeuroSearch Pharmaceuticals and BioMarin. His translational work applied fundamental physiological findings to regeneration in injured peripheral nerve, and management of migraine aura and cardiac arrhythmias, particularly atrial fibrillation and sudden cardiac death. Some of this work received widespread media coverage, including features in BBC News, and The Times, Independent, Daily Telegraph and Guardian. His modernized classification of clinically used anti-arrhythmic drugs was adopted in International, European Society of Cardiology (ESC), 2025 clinical therapeutic guidelines.

Selected publications

Books and monographs

Journals